What is the mechanism of APOL1 trypanolysis?

Abstract

This systematic review looks at how Apolipoprotein L1 (APOL1) works to kill African trypanosomes and how some of these parasites are able to escape this defence. APOL1 is an important part of trypanosome lytic factors (TLFs) and helps protect humans from most African trypanosome infections. However, human-infective subspecies such as Trypanosoma brucei rhodesiense and T. b. gambiense have developed ways to resist its effects. A structured search was carried out using the PIIO framework to find relevant primary research studies. In total, 18 studies were selected based on the inclusion criteria and used to identify the main mechanisms involved. Overall, the evidence suggests that APOL1 acts through several steps. It is delivered to the parasite through TLF complexes, taken up by endocytosis, and then activated in acidic compartments داخل الخلية. This allows it to insert into membranes and form ion channels, which disrupt the parasite’s internal balance and lead to swelling and lysis. The review also shows that trypanosomes use different strategies to avoid being killed. T. b. rhodesiense produces a protein that directly blocks APOL1, while T. b. gambiense reduces its uptake and strengthens its internal membranes. In addition, APOL1 variants (G1 and G2) can overcome some of these resistance mechanisms, but they are also linked to a higher risk of kidney disease. In general, APOL1 appears to act mainly through ion channel formation, although some aspects of its movement داخل الخلية and exact mechanism are still not fully understood.